Avidity Partners Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-675,000
| Closed | -$2.53M | – | 99 |
|
|
2024
Q1 | $2.53M | Buy |
+675,000
| New | +$2.53M | 0.08% | 82 |
|
|
2023
Q4 | – | Sell |
-1,034,294
| Closed | -$8.64M | – | 81 |
|
|
2023
Q3 | $8.64M | Sell |
1,034,294
-3,303,106
| -76% | -$27.6M | 0.35% | 67 |
|
|
2023
Q2 | $57.7M | Buy |
4,337,400
+524,800
| +14% | +$6.98M | 2.01% | 18 |
|
|
2023
Q1 | $44.1M | Buy |
+3,812,600
| New | +$44.1M | 1.47% | 27 |
|